Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma

被引：0
|
作者：
Snehalatha Diddi
Swarna Bale
Gauthami Pulivendala
Chandraiah Godugu
机构：
[1] National Institute of Pharmaceutical Education and Research (NIPER),Department of Regulatory Toxicology
来源：
Inflammopharmacology | 2019年 / 27卷
关键词：
Scleroderma; Nimbolide; Bleomycin; EMT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：139 / 149
页数：10
相关论文
共 50 条
  • [31] Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma
    Matsushita, M
    Yamamoto, T
    Nishioka, K
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 135 (04) : 348 - 356
  • [32] Impaired wound healing in bleomycin-induced murine scleroderma: a new model of wound retardation
    Tatsuo Maeda
    Toshiyuki Yamamoto
    Toru Imamura
    Ryoji Tsuboi
    Archives of Dermatological Research, 2016, 308 : 87 - 94
  • [33] Ivermectin ameliorates bleomycin-induced lung fibrosis in male rats by inhibiting the inflammation and oxidative stress
    Razi, Fatemeh Habibi
    Jafari, Razieh Mohammad
    Manavi, Mohammad Amin
    Sheibani, Mohammad
    Rashidian, Amir
    Tavangar, Seyed Mohammad
    Beighmohammadi, Mohammad Taghi
    Dehpour, Ahmad Reza
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2024, 46 (02) : 183 - 191
  • [34] Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
    Yuan, Yuan
    Li, Yali
    Qiao, Guoqiang
    Zhou, Yilu
    Xu, Zijian
    Hill, Charlotte
    Jiang, Zhenglin
    Wang, Yihua
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [35] Lack of SMAD3 modulates the development of dermal fibrosis in bleomycin-induced murine scleroderma.
    Lakos, G
    Takagawa, S
    Oyenola, O
    Varga, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S155 - S155
  • [36] Effect Of Chronic Intermittent Hypoxia In A Murine Model Of Bleomycin-Induced Pulmonary Fibrosis
    Gille, T. F.
    Didier, M.
    Rotenberg, C.
    Marchant, D.
    Sutton, A.
    Valeyre, D.
    Nunes, H.
    Boncoeur, E.
    Planes, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [37] CpG oligodeoxynucleotides ameliorate the development of bleomycin-induced pulmonary fibrosis in a murine model
    Sigurdarson, S
    Businga, TR
    Lemish, JE
    Krieg, AM
    Kline, JN
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A74 - A74
  • [38] Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
    Xue, Tongtong
    Zhang, Qianyi
    Zhang, Tiantian
    Meng, Lingxin
    Liu, Jing
    Chai, Dan
    Liu, Yuming
    Yang, Zhongyi
    Jiao, Ran
    Cui, Yunyao
    Gao, Jingjing
    Li, Xiaohe
    Xu, Aiguo
    Zhou, Honggang
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [39] Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats
    Raish, Mohammad
    Ahmad, Ajaz
    Ansari, Mushtaq Ahmad
    Ahad, Abdul
    Al-Jenoobi, Fahad I.
    Al-Mohizea, Abdullah M.
    Khan, Altaf
    Ali, Naushad
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 108 : 224 - 231
  • [40] Tumor necrosis factor-α processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma
    Terao, Mika
    Murota, Hiroyuki
    Kitaba, Shun
    Katayama, Ichiro
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (01) : 38 - 43
12345